Drugs Made in America Acquisition (DMAAU) Competitors $10.58 0.00 (0.00%) As of 07/31/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock DMAAU vs. ONCHU, ASPCU, AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, and ANSCUShould you be buying Drugs Made in America Acquisition stock or one of its competitors? The main competitors of Drugs Made in America Acquisition include 1RT Acquisition (ONCHU), A SPAC III Acquisition (ASPCU), AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), and Agriculture & Natural Solutions Acquisition (ANSCU). These companies are all part of the "trading" industry. Drugs Made in America Acquisition vs. Its Competitors 1RT Acquisition A SPAC III Acquisition AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition Drugs Made in America Acquisition (NASDAQ:DMAAU) and 1RT Acquisition (NASDAQ:ONCHU) are both investment offices industry companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends. Which has better valuation & earnings, DMAAU or ONCHU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDrugs Made in America AcquisitionN/AN/AN/AN/AN/A1RT AcquisitionN/AN/AN/AN/AN/A Is DMAAU or ONCHU more profitable? Company Net Margins Return on Equity Return on Assets Drugs Made in America AcquisitionN/A N/A N/A 1RT Acquisition N/A N/A N/A Does the media prefer DMAAU or ONCHU? In the previous week, Drugs Made in America Acquisition's average media sentiment score of 0.00 equaled 1RT Acquisition'saverage media sentiment score. Company Overall Sentiment Drugs Made in America Acquisition Neutral 1RT Acquisition Neutral SummaryDrugs Made in America Acquisition and 1RT Acquisition tied by winning 0 of the 0 factors compared between the two stocks. Get Drugs Made in America Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAAU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DMAAU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DMAAU vs. The Competition Export to ExcelMetricDrugs Made in America AcquisitionInvestment Offices IndustryFinance SectorNASDAQ ExchangeMarket CapN/A$178.82M$12.04B$9.51BDividend YieldN/AN/A5.62%4.08%P/E RatioN/AN/A19.7423.80Price / SalesN/AN/A25.9366.65Price / CashN/A36,784.7921.3357.96Price / BookN/AN/A2.095.55Net IncomeN/A-$160K$1.00B$259.03M7 Day Performance0.76%0.06%-2.46%-4.59%1 Month Performance1.83%1.03%-0.96%4.46%1 Year PerformanceN/A6.67%537.06%18.03% Drugs Made in America Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DMAAUDrugs Made in America AcquisitionN/A$10.58flatN/AN/A$0.00N/A0.002Lockup ExpirationONCHU1RT AcquisitionN/A$10.52+0.4%N/AN/A$0.00N/A0.002Positive NewsASPCUA SPAC III AcquisitionN/A$10.50+1.3%N/AN/A$0.00N/A0.00N/APositive NewsGap UpAGBAWAGBA GroupN/A$0.08-5.4%N/A-72.3%$0.00$38.55M0.00152Gap UpAGNCPAGNC InvestmentN/A$25.35+0.2%N/A+5.6%$0.00$584M0.0050Short Interest ↑AGNCOAGNC InvestmentN/A$25.50+0.0%N/A+3.3%$0.00$584M0.0050AGNCNAGNC InvestmentN/A$25.550.0%N/A-0.5%$0.00$584M0.0050AGNCMAGNC InvestmentN/A$25.12+0.1%N/A-0.5%$0.00$584M0.0050AGNCLAGNC InvestmentN/A$24.75flatN/A+2.6%$0.00$584M0.0050Positive NewsANSCWAgriculture & Natural Solutions AcquisitionN/A$0.21+0.0%N/A+43.5%$0.00N/A0.00N/APositive NewsANSCUAgriculture & Natural Solutions AcquisitionN/A$10.77+0.2%N/AN/A$0.00N/A0.00N/APositive News Related Companies and Tools Related Companies 1RT Acquisition Competitors A SPAC III Acquisition Competitors AGBA Group Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors Agriculture & Natural Solutions Acquisition Competitors Agriculture & Natural Solutions Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DMAAU) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made in America Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made in America Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DMAAU Stock Alerts